Neurocore Brings Focus to ADHD Treatment

Neurocore has conducted a generous amount of focused research toward Attention Deficit Hyperactivity Disorder (ADHD), one of the most common childhood neurodevelopmental disorders. Categorized as impulsive, inattentive, or hyperactive, ADHD is linked to debilitating conditions such as anxiety, poor sleep quality, vision issues, and learning disabilities among others. Also, according to recent studies, it may be hereditary. Although ADHD usually begins in childhood, ADHD can continue well into adulthood and can have negative effects upon school, work, relationships, as well as even lead to substance abuse if left untreated. Neurocore recognizes the need to find and use effective treatments for individuals suffering from this disorder. In fact, treating ADHD is the most researched application of all clinical applications of neurofeedback. Brain mapping and neurofeedback have become viable treatment alternatives to traditional treatment methods such as medication and talk therapy.

https://twitter.com/neurocore

J.R. Lubar first demonstrated the effect of neurofeedback on ADHD in 1976. That information coupled with UCLA’s development of qEEG technology during this time allowed researchers to determine possible root causes of the disorder, specifically those involving theta and beta waves. Building upon this knowledge, Neurocore has had tremendous success treating children, teens, and adults with ADHD using neurotherapy. A high perecentage (over 80%) of the thousands of children treated experienced a significant reduction in symptoms associated with ADHD and over half went below symptomatic thresholds. Learn more about Neurocore at Crunchbase.

Neurocore’s diagnostic procedures include the use of a qEEG to measure brainwave activity. A comparison of those results to thousands of other patients’ results helps to pinpoint ADHD. Other diagnostic tools used include Heart Rate Variability, a Child Behavior Checklist (CBCL) for children, and an Adult Self-Report (ASR) for adults. Use of these tools gives clinicians a clearer idea of how ADHD affects an individual. Once all the information is gathered and a brain map is received, neurofeedback and biofeedback treatments begin, setting patients on a pathway to management of and relief from debilitating ADHD symptoms. Read more about Neurocore at glassdoor.com.

Comments are closed.